Publications by authors named "Ruilei Tang"

Claim this Profile
C
Cost-effectiveness of RAS screening before monoclonal antibodies therapy in metastatic colorectal cancer based on FIRE3 Study.
Feng Wen, Yu Yang, Pengfei Zhang, Jian Zhang, Jing Zhou, Ruilei Tang

Cancer Biol Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial.
Jing Zhou, Rongce Zhao, Feng Wen, Pengfei Zhang, Ruilei Tang

Medicine (Baltimore)· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trials.
Jing Zhou, Rongce Zhao, Feng Wen, Pengfei Zhang, Yifan Wu, Ruilei Tang

Tumori· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vesicular stomatitis virus is a potent agent for the treatment of malignant ascites.
Yi Zhou, Feng Wen, Pengfei Zhang, Ruilei Tang, Qiu Li

Oncol Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma.
Pengfei Zhang, Yu Yang, Feng Wen, Xiaofeng He, Ruilei Tang

Eur J Gastroenterol Hepatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study.
Jing Zhou, Rongce Zhao, Feng Wen, Pengfei Zhang, Ruilei Tang

Med Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of tiopronin for the prevention of chemotherapy-related liver toxicity in advanced colorectal cancer patients treated with mFOLFOX7: a prospective analysis.
Xiao-Peng Li, Feng Wen, Wu Yang, Yi-Bo Deng, Meng Li, Rui-Lei Tang

Tumori· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials.
Feng Wen, Ke Yao, Ze-Dong Du, Xiao-Feng He, Peng-Fei Zhang, Rui-Lei Tang

World J Gastroenterol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.
Feng Wen, Ruilei Tang, Yaxiong Sang, Meng Li, Qiancheng Hu

Cancer Sci· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer.
Jianping He, Feng Wen, Xude Yin, Pengfei Zhang, Zedong Du, Ruilei Tang

Anticancer Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis